Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Granulocyte colony stimulating factor - Xenetic Biosciences/SynBio

Next Previous
Search
Drug Profile

Granulocyte colony stimulating factor - Xenetic Biosciences/SynBio

Alternative Names: Polysialic G-CSF - Xenetic Biosciences; StimuXen; SYN 20111504RU

Latest Information Update: 02 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lipoxen Technologies; Serum Institute of India
  • Developer Serum Institute of India; SynBio; Xenetic Biosciences
  • Class Granulocyte colony-stimulating factors
  • Mechanism of Action Granulocyte colony stimulating factor replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Neutropenia

Most Recent Events

  • 27 Mar 2017 Xenetic Biosciences has patent protection for PolyXen™ platform technology in Europe, Asia and North America, including USA
  • 16 Jun 2014 Granulocyte colony stimulating factor polysialic licensed to SynBio worldwide prior to April 2014
  • 15 Apr 2014 Preclinical trials in Neutropenia in Russia (Parenteral) prior to April 2014

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top